Structural dynamics at the active site of the cancer-associated flavoenzyme NQO1 probed by chemical modification with PMSF

FEBS Lett. 2023 Nov;597(21):2687-2698. doi: 10.1002/1873-3468.14738. Epub 2023 Sep 30.

Abstract

A large conformational heterogeneity of human NAD(P)H:quinone oxidoreductase 1 (NQO1), a flavoprotein associated with various human diseases, has been observed to occur in the catalytic site of the enzyme. Here, we report the X-ray structure of NQO1 with phenylmethylsulfonyl fluoride (PMSF) at 1.6 Å resolution. Activity assays confirmed that, despite being covalently bound to the Tyr128 residue at the catalytic site, PMSF did not abolish NQO1 activity. This may indicate that the PMSF molecule does not reduce the high flexibility of Tyr128, thus allowing NADH and DCPIP substrates to bind to the enzyme. Our results show that targeting Tyr128, a key residue in NQO1 function, with small covalently bound molecules could possibly not be a good drug discovery strategy to inhibit this enzyme.

Keywords: PMSF; X-ray crystallography; cancer; flavoenzyme; human NQO1.

MeSH terms

  • Catalytic Domain
  • Humans
  • NAD(P)H Dehydrogenase (Quinone)* / chemistry
  • Neoplasms*
  • Phenylmethylsulfonyl Fluoride

Substances

  • NAD(P)H Dehydrogenase (Quinone)
  • NQO1 protein, human
  • Phenylmethylsulfonyl Fluoride